Indivior plc (GB:INDV) has released an update.
Indivior PLC, a pharmaceutical company specializing in treatments for substance use disorders and mental illnesses, has announced participation in two key investor events: the 21st Annual Craig-Hallum Institutional Investor Conference and the Jefferies Global Healthcare Conference. Investors interested in one-on-one meetings can get in touch with their Craig-Hallum representatives, while the presentation by CEO Mark Crossley will be publicly accessible via a webcast. The company aims to transform the treatment of substance use disorders into a manageable chronic condition with a global reach in treatment availability.
For further insights into GB:INDV stock, check out TipRanks’ Stock Analysis page.
